Pure motor lumbosacral radiculopathy after intrathecal chemotherapy.
D
D
Santos-García
J
J
Pardo
F
F
Vázquez
M J
MJ
Rabuñal-Martínez
A I
AI
Martín-Vigo
R
R
de la Fuente-Fernández
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001215:Asparaginase / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000009:adverse effects; D007278:Injections, Spinal / Q000009:adverse effects*; D008159:Lumbar Vertebrae; D008279:Magnetic Resonance Imaging; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D020335:Paraparesis / Q000139:chemically induced; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D011843:Radiculopathy / Q000139:chemically induced*; D012447:Sacrum; D013126:Spinal Nerve Roots / Q000187:drug effects* / Q000473:pathology*; D014750:Vincristine / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D003561:Cytarabine; D014750:Vincristine; D003907:Dexamethasone; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D006854:Hydrocortisone; D008727:Methotrexate